vimarsana.com
Home
Live Updates
Nevro Announces Consensus Statement Supporting High-Frequenc
Nevro Announces Consensus Statement Supporting High-Frequenc
Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic Neuropathy
Nevro Corp. , a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced the publication of a consensus statement summarizing recommendations based on...
Related Keywords
Redwood City ,
California ,
United States ,
American ,
Angie Mccabe ,
Erika Petersen ,
Kevin Thornal ,
Nevro Corp ,
Diabetes Research ,
World Health Organization ,
Instagram ,
University Of Arkansas ,
Facebook ,
Worldwide Initiative For Diabetes Education ,
Investor Relations Corporate Communications ,
Linkedin ,
Prnewswire Nevro Corp ,
American Diabetes Association ,
Spinal Cord Stimulation Therapy ,
Refractory Painful Diabetic ,
Worldwide Initiative ,
Diabetes Education ,
Painful Diabetic Neuropathy ,
Virtual Global ,
Clinical Practice ,
David Caraway ,
Investor Relations ,
Painful Diabetic Peripheral ,
Suboptimal Treatment ,
Diabetic Peripheral Neuropathic Pain ,